Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 31, 2009
Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptorsMinoru Kameda, Makoto Ando, Chisato Nakama, et al.Journal of Medicinal Chemistry|June 16, 2009
Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitorsTsuyoshi Nagase, Toshiyuki Takahashi, Takahide Sasaki, et al.Journal of Medicinal Chemistry|April 25, 2009
Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitorsToshiyuki Takahashi, Tsuyoshi Nagase, Takahide Sasaki, et al.American Journal of Physiology. Endocrinology and Metabolism|November 28, 2002
Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormoneAkira Gomori, Akane Ishihara, Masahiko Ito, et al.Bioorganic & Medicinal Chemistry|July 15, 2009
Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitorsTakahide Sasaki, Tsuyoshi Nagase, Toshiyuki Takahashi, et al.Proceedings of the National Academy of Sciences of the United States of America|September 7, 2006
Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitusRyo Yoshimoto, Yasuhisa Miyamoto, Ken Shimamura, et al.American Journal of Physiology. Endocrinology and Metabolism|January 30, 2003
Characterization of MCH-mediated obesity in miceMasahiko Ito, Akira Gomori, Akane Ishihara, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2009
Synthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H(3) receptor inverse agonistsTakahide Sasaki, Toshiyuki Takahashi, Tsuyoshi Nagase, et al.Journal of Medicinal Chemistry|October 10, 2008
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonistsTsuyoshi Nagase, Takashi Mizutani, Etsuko Sekino, et al.European Journal of Pharmacology|January 5, 2010
Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6Ken Shimamura, Akira Nagumo, Yasuhisa Miyamoto, et al.Pageof 7